Ashland Inc. (ASH) stock

ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 6/3025% above fair value

$76.47+1.20 (+1.59%)

Close on Nov 13, 2026Market cap $3.50BP/E –Yield 2.14%

Earnings

Ashland's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 1, 2027

Q1 FY2027 · estimated, after the close

Revenue, Q4 FY2026

$498.00M

+4.2% on a year earlier

Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense, Q4 FY2026

$1.12

$1.08 a year earlier

Latest guidance

Issued

Nov 3, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Ashland's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q1 FY2027ended Dec 31, 2026	Feb 1, 2027Expected	–	–	–	–	–
Q4 FY2026ended Sep 30, 2026	Nov 3, 2026after the close	$498.00M	+4.2%	-$0.35	$1.12	Release
Q3 FY2026ended Jun 30, 2026	Jul 28, 2026after the close	$497.00M	+7.3%	$0.35	$1.02	Release
Q2 FY2026ended Mar 31, 2026	Apr 28, 2026after the close	$482.00M	+0.6%	$0.32	$0.91	Release
Q1 FY2026ended Dec 31, 2025	Feb 2, 2026after the close	$386.00M	-4.7%	-$0.26	$0.26	Release
Q4 FY2025ended Sep 30, 2025	Nov 4, 2025after the close	$478.00M	-8.4%	$0.71	$1.08	Release
Q3 FY2025ended Jun 30, 2025	Jul 29, 2025after the close	$463.00M	-14.9%	-$16.21	$1.04	Release
Q2 FY2025ended Mar 31, 2025	Apr 30, 2025after the close	$479.00M	-16.7%	$0.65	$0.99	Release
Q1 FY2025ended Dec 31, 2024	Jan 28, 2025after the close	$405.00M	-14.4%	-$3.50	$0.28	Release
Q4 FY2024ended Sep 30, 2024	Nov 6, 2024after the close	$522.00M	+0.8%	$0.39	$1.26	Release
Q3 FY2024ended Jun 30, 2024	Aug 6, 2024after the close	$544.00M	-0.4%	$0.60	$1.49	Release
Q2 FY2024ended Mar 31, 2024	Apr 30, 2024after the close	$575.00M	-4.6%	$2.39	$1.27	Release
Q1 FY2024ended Dec 31, 2023	Jan 30, 2024after the close	$473.00M	-9.9%	$0.51	$0.45	Release
Q4 FY2023ended Sep 30, 2023	Nov 8, 2023after the close	$518.00M	-17.9%	-$0.07	$0.41	Release
Q3 FY2023ended Jun 30, 2023	Jul 25, 2023after the close	$546.00M	-15.2%	$0.79	$1.23	Release
Q2 FY2023ended Mar 31, 2023	May 2, 2023after the close	$603.00M	-0.2%	$1.67	$1.43	Release
Q1 FY2023ended Dec 31, 2022	Jan 31, 2023after the close	$525.00M	+2.5%	$0.73	$0.97	Release
Q4 FY2022ended Sep 30, 2022	Nov 7, 2022after the close	$631.00M	+6.8%	$1.09	$1.46	Release
Q3 FY2022ended Jun 30, 2022	Jul 26, 2022after the close	$644.00M	–	$0.65	$1.89	Release
Q2 FY2022ended Mar 31, 2022	Apr 26, 2022after the close	$604.00M	–	$0.66	$1.50	Release
Q1 FY2022ended Dec 31, 2021	Feb 1, 2022after the close	$512.00M	–	$0.83	$0.88	Release
Q4 FY2021ended Sep 30, 2021	Nov 9, 2021after the close	$591.00M	–	$0.72	$1.22	Release
Q3 FY2021ended Jun 30, 2021	Jul 27, 2021after the close	–	–	–	–	Filing
Q2 FY2021ended Mar 31, 2021	Apr 28, 2021after the close	–	–	–	–	Filing
Q1 FY2021ended Dec 31, 2020	Feb 3, 2021after the close	–	–	–	–	Filing
Q4 FY2020ended Sep 30, 2020	Nov 10, 2020after the close	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Ashland's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
SalesGAAP	FY2027	$1.91B – $1.98B	–	New	Nov 3, 2026
Adjusted EBITDAnon-GAAP	FY2027	$405.00M – $435.00M	–	New	Nov 3, 2026

Guidance vs results

The last range Ashland gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2026	Revenue	$1.84B – $1.87B	$1.86BΣ4Q	Within range
FY2025	Revenue	$1.83B – $1.85B	$1.83BΣ4Q	Within range
Q4 FY2024	Revenue	$530.00M – $540.00M	$522.00M	Below range
Q3 FY2024	Revenue	$560.00M – $580.00M	$544.00M	Below range
Q2 FY2024	Revenue	$565.00M – $585.00M	$575.00M	Within range
Q1 FY2024	Revenue	$470.00M – $490.00M	$473.00M	Within range

Guidance history

Every forecast Ashland put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Nov 3, 2026	Adjusted EBITDA	FY2027	$405.00M – $435.00M	New
Nov 3, 2026	Sales	FY2027	$1.91B – $1.98B	New
Jul 28, 2026	capital expenditures	FY2026	$90.00M	New
Jul 28, 2026	Adjusted EBITDA	FY2026	$385.00M – $400.00M	Reaffirmed
Jul 28, 2026	sales	FY2026	$1.84B – $1.87B	Reaffirmed
Apr 28, 2026	capital expenditures	FY2026	$100.00M	Reaffirmed
Apr 28, 2026	Adjusted EBITDA	FY2026	$385.00M – $400.00M	Lowered
Apr 28, 2026	Ongoing Free Cash Flow Conversion	FY2026	50%	Reaffirmed
Apr 28, 2026	Sales	FY2026	$1.84B – $1.87B	Lowered
Feb 2, 2026	capital expenditures	FY2026	$100.00M	Reaffirmed
Feb 2, 2026	Adjusted EBITDA	FY2026	$400.00M – $420.00M	Lowered
Feb 2, 2026	Sales	FY2026	$1.84B – $1.91B	Reaffirmed
Nov 4, 2025	capital expenditures	FY2026	$100.00M	New
Nov 4, 2025	Adjusted EBITDA	FY2026	$400.00M – $430.00M	New
Nov 4, 2025	Ongoing Free Cash Flow Conversion	FY2026	50%	New
Nov 4, 2025	Sales	FY2026	$1.84B – $1.91B	New
Jul 29, 2025	Adjusted EBITDA	FY2025	$400.00M – $410.00M	New
Jul 29, 2025	sales	FY2025	$1.83B – $1.85B	New
Apr 30, 2025	adjusted EBITDA	FY2025	$400.00M – $420.00M	Lowered
Apr 30, 2025	sales	FY2025	$1.83B – $1.90B	Lowered
Jan 28, 2025	Adjusted EBITDA	FY2025	$430.00M – $470.00M	Reaffirmed
Jan 28, 2025	sales	FY2025	$1.90B – $2.05B	Reaffirmed
Nov 6, 2024	Adjusted EBITDA	FY2025	$430.00M – $470.00M	New
Nov 6, 2024	sales	FY2025	$1.90B – $2.05B	New
Aug 6, 2024	adjusted EBITDA	Q4 FY2024	$130.00M – $140.00M	New
Aug 6, 2024	adjusted EBITDA	FY2024	$465.00M – $475.00M	Lowered
Aug 6, 2024	sales	Q4 FY2024	$530.00M – $540.00M	New
Aug 6, 2024	sales	FY2024	$2.10B	Lowered
Apr 30, 2024	adjusted EBITDA	Q3 FY2024	$138.00M – $148.00M	New
Apr 30, 2024	adjusted EBITDA	FY2024	$470.00M – $500.00M	Raised
Apr 30, 2024	sales	Q3 FY2024	$560.00M – $580.00M	New
Apr 30, 2024	sales	FY2024	$2.15B – $2.23B	Lowered
Jan 30, 2024	adjusted EBITDA	Q2 FY2024	$115.00M – $125.00M	New
Jan 30, 2024	adjusted EBITDA	FY2024	$460.00M – $500.00M	New
Jan 30, 2024	sales	Q2 FY2024	$565.00M – $585.00M	New
Jan 30, 2024	sales	FY2024	$2.15B – $2.25B	New
Nov 8, 2023	adjusted EBITDA	Q1 FY2024	$55.00M – $65.00M	New
Nov 8, 2023	sales	Q1 FY2024	$470.00M – $490.00M	New
Jul 25, 2023	Adjusted EBITDA	FY2023	$500.00M	Lowered
Jul 25, 2023	sales	FY2023	$2.20B	Lowered
May 2, 2023	Adjusted EBITDA	FY2023	$580.00M – $610.00M	Lowered
May 2, 2023	sales	FY2023	$2.30B – $2.40B	Lowered
Jan 31, 2023	Adjusted EBITDA	FY2023	$600.00M – $650.00M	Reaffirmed
Jan 31, 2023	sales	FY2023	$2.50B – $2.70B	Reaffirmed
Nov 7, 2022	adjusted EBITDA	FY2023	$600.00M – $650.00M	New
Nov 7, 2022	sales	FY2023	$2.50B – $2.70B	New
Jul 26, 2022	Adjusted EBITDA	FY2022	$580.00M – $590.00M	Raised
Jul 26, 2022	sales	FY2022	$2.35B – $2.40B	Raised
Apr 26, 2022	adjusted EBITDA	FY2022	$550.00M – $570.00M	Reaffirmed
Apr 26, 2022	sales	FY2022	$2.25B – $2.35B	New
Feb 1, 2022	adjusted EBITDA	FY2022	$550.00M – $570.00M	Reaffirmed
Feb 1, 2022	sales	FY2022	$2.25B – $2.35B	Reaffirmed
Nov 9, 2021	adjusted EBITDA	FY2022	$550.00M – $570.00M	New
Nov 9, 2021	sales	FY2022	$2.25B – $2.35B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.